News

The Food and Drug Administration is convening a public workshop titled “Development of Inhaled Antibacterial Drugs for Cystic Fibrosis and Non-Cystic Fibrosis Bronchiectasis” on Wednesday, June 27th from 8:30pm to 4:30pm ET. The purpose of this workshop is to discuss the clinical trial design challenges...
Read More
The American Thoracic Society Public Advisory Roundtable (ATS/PAR) is proud to present their 12th Annual “Meet the Experts” Patient/Family Forum at the Manchester Grand Hyatt Hotel on Saturday, May 19th, 2018 from 10 am to 2 pm in San Diego, CA. This is a free...
Read More
We hope to see you at the 2018 NTM & Bronchiectasis Physician/Patient Conference, to be held on May 17, 2018 at the Estancia La Jolla Hotel in La Jolla, CA. REGISTRATION IS NOW OPEN!! Health care professionals and industry, click here to register for the...
Read More
Aradigm, the company that submitted Linhaliq to the FDA for approval, announced that they had received a complete response letter (CRL) from the FDA stating that they would not approve the treatment at this time. Many of you have communicated recently with the FDA about...
Read More
NTM Info & Research and the COPD Foundation is happy to announce the release of the Bronchiectasis and NTM Information Line: 1-833-411-LUNG (5864). The Bronchiectasis and NTM Information Line is a toll-free number managed by the C.O.P.D. Information Line for peer-to-peer information and referrals on...
Read More
by Amy Leitman   At the end of June I attended DIA 2016, the annual conference for the Drug Information Association, as part of their Patient Advocacy Fellowship Program. The Fellowship Program is a major initiative designed to build industry awareness of the importance of...
Read More